hematology testing News
-
PixCell Medical Partners with Triolab to Distribute Hematological Analyzer HemoScreen in Sweden
PixCell Medical, innovator of rapid diagnostic solutions at the point-ofcare, today announced a partnership with Triolab, the largest diagnostics distributor in the Nordic and Baltic countries, to be the sole distributor in Sweden of the HemoScreen™, PixCell’s hematology analyzer designed for use at the point of care. “PixCell’s HemoScreen brings lab-quality haematology ...
-
PixCell Medical`s Point-Of-Care Hematology Analyzer Can Play a Key Role in Minimizing Disease Spread
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that The Journal of Applied Laboratory Medicine (JALM) has published a research paper comparing PixCell's HemoScreen™ and its analysis method to standard lab analyzers. Researchers concluded that PixCell's HemoScreen™, a miniature, easy-to-use, AI and machine vision-enabled hematology ...
-
PixCell Medical Announces Acquisition by Soulbrain Holdings
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that Soulbrain Holdings has acquired all controlling PixCell shares, as well as investing in the company, making Soulbrain the majority shareholder of PixCell Medical. The acquisition of PixCell aligns with Soulbrain's recent strategic transition into the healthcare and in-vitro diagnostics space. ...
-
PixCell Medical Partners with Axonlab to Distribute Point-of-Care Hematological Analyzer HemoScreen Across Europe
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, today announced an exclusive distribution agreement with Axonlab, a leader in point-of-care testing in Europe providing the healthcare sector with equipment and services in the fields of medical diagnostics, life science, and software solutions, to distribute the HemoScreen™, PixCell's hematology analyzer, in key ...
-
First Patient Dosed in UroGen Pharma’s Home Instillation Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (LG IR-NMIBC)
Study explores opportunity to shift from clinic to home instillation of this promising non-surgical treatment Potential to transform care and access to treatment for this growing patient population UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat urothelial and specialty cancers, today announced that the ...
-
Sysmex Continues to Evolve Its Hematology Product Portfolio
Since its founding in 1968, Sysmex has developed its business by focusing on the hematology field (blood cell count tests), which analyzes the number, type, and size of red and white blood cells as well as platelets. Sysmex has adopted a modular concept since the launch of the XN-Series Automated Hematology Analyzer (“XN-Series”) in 2011, combining modules for blood count, smear ...
-
Aidian Appointed Sole Distributor of PixCell Medical’s Point-of-Care Hematological Analyzer HemoScreen in the Nordics
PixCell Medical, innovator of rapid diagnostic solutions at the point-ofcare, today announced a partnership with Aidian, a Finland-based in-vitro diagnostics company providing reliable, fast, and easy-to-use diagnostic tests for primary care. Aidian will serve as the sole distributor of PixCell’s HemoScreen™, a hematology analyzer designed for use at the point of care, with exclusive ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you